Literature DB >> 14555224

Induction of apoptosis by curcumin: mediation by glutathione S-transferase P1-1 inhibition.

Annelyse Duvoix1, Franck Morceau, Sylvie Delhalle, Martine Schmitz, Michaël Schnekenburger, Marie-Madeleine Galteau, Mario Dicato, Marc Diederich.   

Abstract

Expression of glutathione S-transferase P1-1 (GSTP1-1) is correlated to carcinogenesis and resistance of cancer cells against chemotherapeutic agents. Curcumin, a natural compound extracted from Curcuma longa, has shown strong antioxidant and anticancer properties and also the ability to regulate a wide variety of genes that require activating protein 1 and nuclear factor kappaB (NF-kappaB) activation. In the present study, we examined the inhibitory effect of curcumin on the expression of GSTP1-1 mRNA as well as protein, and we correlated this inhibition with the apoptotic effect of curcumin on K562 leukemia cells. Curcumin efficiently inhibited the tumour necrosis factor alpha- and phorbol ester-induced binding of AP-1 and NF-kappaB transcription factors to sites located on the GSTP1-1 gene promoter. TNFalpha-induced GSTP1-1 promoter activity was also inhibited by curcumin as shown by reporter gene assay. In parallel, curcumin induced pro-caspases 8 and 9 as well as poly ADP ribose polymerase cleavage and thus leading to apoptosis in K562 cells. Our results overall add a novel role for curcumin as this chemoprotective compound could contribute to induce apoptosis by its ability to inhibit the GSTP1-1 expression at the level of transcription.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14555224     DOI: 10.1016/s0006-2952(03)00501-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  16 in total

1.  Dietary compounds as potent inhibitors of the signal transducers and activators of transcription (STAT) 3 regulatory network.

Authors:  Anne Trécul; Franck Morceau; Mario Dicato; Marc Diederich
Journal:  Genes Nutr       Date:  2012-01-25       Impact factor: 5.523

Review 2.  Novel targets for prostate cancer chemoprevention.

Authors:  Fazlul H Sarkar; Yiwei Li; Zhiwei Wang; Dejuan Kong
Journal:  Endocr Relat Cancer       Date:  2010-08-16       Impact factor: 5.678

3.  Curcumin therapy in inflammatory bowel disease: a pilot study.

Authors:  Peter R Holt; Seymour Katz; Robert Kirshoff
Journal:  Dig Dis Sci       Date:  2005-11       Impact factor: 3.199

4.  Morphoproteomic confirmation of an activated nuclear factor-кBp65 pathway in follicular thyroid carcinoma.

Authors:  Jing Liu; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2012-03-25

Review 5.  Medicinal plants and cancer chemoprevention.

Authors:  Avni G Desai; Ghulam N Qazi; Ramesh K Ganju; Mahmoud El-Tamer; Jaswant Singh; Ajit K Saxena; Yashbir S Bedi; Subhash C Taneja; Hari K Bhat
Journal:  Curr Drug Metab       Date:  2008-09       Impact factor: 3.731

Review 6.  Glutathione S-Transferases in Cancer.

Authors:  Rahul Raj Singh; Katie M Reindl
Journal:  Antioxidants (Basel)       Date:  2021-04-29

7.  Epigenetics Offer New Horizons for Colorectal Cancer Prevention.

Authors:  Michael Schnekenburger; Marc Diederich
Journal:  Curr Colorectal Cancer Rep       Date:  2012-01-14

8.  Coniferyl Ferulate, a Strong Inhibitor of Glutathione S-Transferase Isolated from Radix Angelicae sinensis, Reverses Multidrug Resistance and Downregulates P-Glycoprotein.

Authors:  Chang Chen; Chuanhong Wu; Xinhua Lu; Zhiyong Yan; Jian Gao; Hui Zhao; Shaojing Li
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-24       Impact factor: 2.629

9.  Time- and dose-dependent effects of curcumin on gene expression in human colon cancer cells.

Authors:  Marjan J Van Erk; Eva Teuling; Yvonne CM Staal; Sylvie Huybers; Peter J Van Bladeren; Jac MMJG Aarts; Ben Van Ommen
Journal:  J Carcinog       Date:  2004-05-12

Review 10.  Regulation of epigenetic traits of the glutathione S-transferase P1 gene: from detoxification toward cancer prevention and diagnosis.

Authors:  Michael Schnekenburger; Tommy Karius; Marc Diederich
Journal:  Front Pharmacol       Date:  2014-07-16       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.